Johnson & Johnson to Begin COVID-19 Vaccine Trials On Humans In July

Johnson & Johnson plans to start its coronavirus vaccine trials two months early due to promising research results. The company will test 1045 healthy adults in the US and Belgium, with some receiving the vaccine and others a placebo. If successful, they aim to produce 1 billion units in 2021. Johnson & Johnson is among ten companies working on a safe and effective vaccine, with experts estimating a 12 to 18-month development period.

Why is Johnson & Johnson starting its vaccine trials earlier than planned?

• To meet public demand

• To compete with other companies

• Because of strong research results

• Due to a government mandate

How many healthy adults does Johnson & Johnson plan to test their vaccine on?

• 500

• 1500

• 1045

• 2000

In which countries will Johnson & Johnson conduct their vaccine trials?

• Canada and Mexico

• France and Italy

• UK and Germany

• US and Belgium

How many companies are working on developing a COVID-19 vaccine according to the transcript?

• 5

• 10

• 15

• 20

What is the estimated time frame for developing a COVID-19 vaccine according to experts?

• 18 to 24 months

• 6 to 9 months

• 9 to 12 months

• 12 to 18 months